This study reports the effects of RO‐BIR2 as single agent or in combination with either TNF‐related apoptosis‐inducing ligand (TRAIL) or chemotherapy on a panel of AML cell lines, primary human AML cells. This evidence concerns the gene TNFSF10 and acute myeloid leukemia.